PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,153,869 | -55.9% | 181,884 | -53.9% | 0.00% | -33.3% |
| Q2 2023 | $7,154,918 | +72245.0% | 394,863 | +6.2% | 0.00% | -50.0% |
| Q1 2023 | $9,890 | +147.5% | 371,803 | +79.8% | 0.01% | +200.0% |
| Q4 2022 | $3,996 | -99.9% | 206,731 | +6.6% | 0.00% | 0.0% |
| Q3 2022 | $4,050,000 | +129.6% | 193,882 | -12.0% | 0.00% | +100.0% |
| Q2 2022 | $1,764,000 | +333.4% | 220,213 | +279.2% | 0.00% | – |
| Q1 2022 | $407,000 | -53.1% | 58,067 | -9.6% | 0.00% | – |
| Q4 2021 | $868,000 | +53.9% | 64,263 | +92.4% | 0.00% | – |
| Q3 2021 | $564,000 | +11.9% | 33,396 | +92.8% | 0.00% | – |
| Q2 2021 | $504,000 | -79.8% | 17,319 | -72.7% | 0.00% | -100.0% |
| Q1 2021 | $2,492,000 | +245.2% | 63,366 | +99.3% | 0.00% | +100.0% |
| Q4 2020 | $722,000 | +86.1% | 31,796 | +85.4% | 0.00% | – |
| Q3 2020 | $388,000 | -82.9% | 17,148 | -75.5% | 0.00% | -100.0% |
| Q2 2020 | $2,274,000 | – | 70,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |